Related Experiment Video
Updated: Aug 11, 2026

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
Interactions mediating bacterial translocation in the immature intestine
1Woman and Children's Health Research Foundation, Children's Hospital of Buffalo, SUNY, NY 14222, USA.
Insights
Bacterial translocation (BT) from the gut to mesenteric lymph nodes is a concern, especially in newborns. Adherent bifidobacteria show promise in preventing pathogen colonization and reducing BT, offering potential biotherapeutic strategies.
Area of Science:
- Microbiology
- Immunology
- Neonatal Medicine
Background:
- Systemic disease can arise from enterovirulent bacteria and toxins translocating from the gut lumen to mesenteric lymph nodes (MLN).
- Bacterial translocation (BT) is a significant concern in the developing gut of premature newborns, with anaerobic bacteria rarely observed to translocate.
- Phagocytic cells, such as macrophages, may play a crucial role in the process of bacterial translocation.
Purpose of the Study:
- To review systemic disease caused by bacterial translocation (BT).
- To investigate the inhibitory effects of adherent human bifidobacterial strains against colonization by diarrheagenic bacteria and viruses.
- To explore the protective role of human breast milk and potential biotherapeutic strategies for combating BT.
Main Methods:
- Testing adherence of bifidobacterial strains to enterocyte-like Caco-2 cells in vitro.
- Investigating the inhibitory effect of adherent bifidobacteria against Escherichia coli O157, Salmonella typhimurium, murine rotavirus, and rhesus rotavirus.
- Utilizing various in vitro and in vivo models to assess bacterial and viral colonization and translocation.
Main Results:
- Adherent human bifidobacterial strains demonstrated inhibitory effects against colonization by specific diarrheagenic bacteria and viruses.
- Human breast milk contains bioactive substances that inhibit bacterial overgrowth and BT.
- Anaerobic bacteria are infrequently observed to translocate to the MLN.
Conclusions:
- Adherent bifidobacteria show potential as a biotherapeutic strategy to inhibit pathogen colonization and reduce bacterial translocation.
- Human breast milk's bioactive components offer protective effects against bacterial overgrowth and BT.
- Stimulating beneficial anaerobic microflora, like Lactobacillus and Bifidobacterium, presents a promising research avenue for treating BT-related diseases.
Abstract:
Systemic disease caused by transmucosal passage of enterovirulent bacteria and toxins from the gut lumen into the mesenteric lymph nodes (MLN) is reviewed, with particular concern for bacterial interactions in the developing gut of premature newborns. Anaerobic bacteria are rarely observed to translocate to the MLN. Bifidobacterial strains have been tested for their abilities to adhere to enterocyte-like Caco-2 cells in culture. We have investigated the inhibitory effect of adherent human bifidobacterial strains against colonization by a number of diarrheagenic bacteria (Escherichia coli O157; Salmonella typhimurium) and viruses (murine and rhesus rotavirus), in various in vitro and in vivo models. The phagocytic cell (macrophage) may be a key factor in bacterial translocation (BT). Human breast milk contains abundant bioactive substances (immunologic, nutritional) that provide protective effects through inhibition of bacterial overgrowth and BT. New biotherapeutic therapies that stimulate beneficial anaerobic microflora (Lactobacillus, Bifidobacterium) are promising avenues of research to combat BT in disease treatment.
Related Concept Videos
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Bacterial Translocation and Protein Secretion
Microbial Interactions: Cooperation
Microbiota Modulation by Antibiotics
Colonisation of Pathogens
Determinants of Bacterial Pathogenicity and Virulence

